&nbsp;

Sep 2025

Drug

PERTuzumab

Other Name(s): Perjeta®

Quick Link(s):

Sep 2022

Drug

pomalidomide

Other Name(s): Pomalyst®

Quick Link(s):

Apr 2025

Drug

ponatinib

Other Name(s): Iclusig®

Quick Link(s):

Aug 2023

Drug

pembrolizumab

Other Name(s): Keytruda®

Quick Link(s):

Sep 2025

Regimen

FC

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

fludarabine,

cyclophosphamide

... Show more tags

Quick Link(s):

Regimen Monograph

Apr 2016

Regimen

FLOX

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Adjuvant

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

FLUD

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

fludarabine

... Show more tags

Quick Link(s):

Regimen Monograph

Apr 2016

Regimen

FU(CIV-RT)

Cancer Type:

Gastrointestinal,

Pancreas

Intent: Adjuvant, Palliative

Drugs Used:

fluorouracil

... Show more tags

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

PCV

Cancer Type:

Central Nervous System

Intent: Adjuvant, Curative, Palliative

Funding:

ODB - General Benefit

procarbazine

ODB - General Benefit

lomustine

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2023

Regimen

FCM

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2016

Regimen

FLUD+R

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

Drugs Used: